Renalytix plc - ADS (RNLXY)

CUSIP: 75973T101

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / ADS
Total 13F shares
4,848,420
Share change
-95,259
Total reported value
$77,575,000
Price per share
$16.00
Number of holders
19
Value change
-$1,523,390
Number of buys
9
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 75973T101?
CUSIP 75973T101 identifies RNLXY - Renalytix plc - ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Renalytix plc - ADS (RNLXY) as of Q4 2020

As of 31 Dec 2020, Renalytix plc - ADS (RNLXY) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,848,420 shares. The largest 10 holders included GILDER GAGNON HOWE & CO LLC, Parian Global Management LP, ArrowMark Colorado Holdings LLC, FIL Ltd, Pentwater Capital Management LP, SILVERARC CAPITAL MANAGEMENT, LLC, GOFEN & GLOSSBERG LLC /IL/, MILLENNIUM MANAGEMENT LLC, Manatuck Hill Partners, LLC, and PINNACLE ASSOCIATES LTD. This page lists 19 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.